We are live on
!
Find out more
Schroder Investment Management Group Portfolio holdings
AUM
$141B
1-Year Est. Return
34.18%
This Fund
S&P 500
This Quarter
Est. Return
+9.22%
1 Year Est. Return
+34.18%
3 Year Est. Return
+121.7%
5 Year Est. Return
+159.58%
10 Year Est. Return
+619.19%
AUM
$128B
AUM Growth
+$9.5B
(+8%)
Cap. Flow
+$1.42B
Cap. Flow
% of AUM
1.11%
Top 10 Holdings %
Top 10 Hldgs %
32.76%
Holding
1,295
New
140
Increased
466
Reduced
522
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$556M |
| 2 |
Sea Limited
SE
|
+$545M |
| 3 |
Vanguard Total World Stock ETF
VT
|
+$429M |
| 4 |
Full Truck Alliance
YMM
|
+$399M |
| 5 |
Meta Platforms (Facebook)
META
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arm
ARM
|
+$443M |
| 2 |
Elevance Health
ELV
|
+$387M |
| 3 |
KLA
KLAC
|
+$269M |
| 4 |
Arista Networks
ANET
|
+$246M |
| 5 |
Ferguson
FERG
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.45% |
| 2 | Communication Services | 14.45% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 11.48% |
| 5 | Healthcare | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Kymera Therapeutics
KYMR
$9.51B
| $3.61M | ﹤0.01% |
61,640
-48,573
| -44% | -$2.19M |
|
802
Keysight
KEYS
$60.5B
| $3.56M | ﹤0.01% |
20,564
-1,759
| -8% | -$293K |
|
803
Levi Strauss
LEVI
$8.63B
| $3.52M | ﹤0.01% |
+151,109
| New | +$3.21M |
|
804
General Mills
GIS
$20.8B
| $3.49M | ﹤0.01% |
69,133
-7,355
| -10% | -$369K |
|
805
EyePoint Inc
EYPT
$1.16B
| $3.48M | ﹤0.01% |
247,754
-66,225
| -21% | -$762K |
|
806
Fidelity National Information Services
FIS
$22.8B
| $3.47M | ﹤0.01% |
52,741
-14,543
| -22% | -$1.06M |
|
807
Occidental Petroleum
OXY
$57.7B
| $3.46M | ﹤0.01% |
71,834
-39,306
| -35% | -$1.78M |
|
808
Dyne Therapeutics
DYN
$4.85B
| $3.41M | ﹤0.01% |
275,596
+69,970
| +34% | +$798K |
|
809
Cboe Global Markets
CBOE
$30.6B
| $3.4M | ﹤0.01% |
13,820
-6,036
| -30% | -$1.45M |
|
810
Privia Health
PRVA
$2.78B
| $3.39M | ﹤0.01% |
138,915
-1,683
| -1% | -$36.2K |
|
811
Immatics
IMTX
$1.31B
| $3.39M | ﹤0.01% |
427,994
| – | – |
|
|
ACLX
812
DELISTED
Arcellx
ACLX
| $3.36M | ﹤0.01% |
42,478
-17,522
| -29% | -$1.26M |
|
|
CMPS
813
Compass Pathways
CMPS
$1.84B
| $3.35M | ﹤0.01% |
570,462
+25,741
| +5% | +$116K |
|
814
Corebridge Financial
CRBG
$15.3B
| $3.31M | ﹤0.01% |
100,287
-94,794
| -49% | -$3.24M |
|
815
HubSpot
HUBS
$12B
| $3.28M | ﹤0.01% |
7,016
-322
| -4% | -$162K |
|
|
VISN
816
Vistance Networks Inc
VISN
$2.62B
| $3.25M | ﹤0.01% |
+210,779
| New | +$2.74M |
|
817
W.P. Carey
WPC
$16.3B
| $3.24M | ﹤0.01% |
48,302
+16,580
| +52% | +$1.09M |
|
818
BridgeBio Pharma
BBIO
$15.9B
| $3.24M | ﹤0.01% |
+62,357
| New | +$3.04M |
|
819
Microchip Technology
MCHP
$42.2B
| $3.22M | ﹤0.01% |
50,309
-17,686
| -26% | -$1.2M |
|
820
CoStar Group
CSGP
$13.4B
| $3.22M | ﹤0.01% |
38,165
-13,144
| -26% | -$1.16M |
|
821
Archer Daniels Midland
ADM
$38.6B
| $3.18M | ﹤0.01% |
53,253
-12,867
| -19% | -$753K |
|
822
Xenon Pharmaceuticals
XENE
$6.21B
| $3.17M | ﹤0.01% |
81,156
-47,947
| -37% | -$1.69M |
|
|
PONY
823
Pony AI Inc
PONY
$3.62B
| $3.12M | ﹤0.01% |
138,835
-8,174
| -6% | -$124K |
|
824
FirstEnergy
FE
$27.1B
| $3.09M | ﹤0.01% |
67,998
+18,561
| +38% | +$792K |
|
825
Vipshop
VIPS
$6.8B
| $3.08M | ﹤0.01% |
161,411
-105,276
| -39% | -$1.75M |
|
Similar funds
Schroder Investment Management Group's Q3 2025 Portfolio in Review
As of Q3 2025, Schroder Investment Management Group held 1,295 positions worth $128B, up 8% from $118B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Schroder Investment Management Group's Q3 2025 filing shows 140 new, 466 increased, 522 reduced and 115 closed positions. Its largest new stake was Baidu: 1,225,970 shares worth $165M. The largest sale was Arm, an estimated $443M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Communication Services and Financials.
- Schroder Investment Management Group's largest Q3 2025 buy was Baidu: 1,225,970 shares worth $165M.
- Schroder Investment Management Group added most to NVIDIA in Q3 2025, an estimated $556M increase.
- Schroder Investment Management Group's biggest Q3 2025 reduction was Arm, cutting an estimated $443M.
- Schroder Investment Management Group fully exited Globant in Q3 2025, selling an estimated $91.4M.
- Schroder Investment Management Group's ten largest holdings make up 33% of its $128B portfolio in Q3 2025.
- Schroder Investment Management Group opened 140 new positions and closed 115 in Q3 2025.
- Schroder Investment Management Group's portfolio value rose 8% quarter-over-quarter to $128B.
Based on Schroder Investment Management Group's 13F filing for Q3 2025, filed 13 Nov 2025.